Did Mylan Win By Losing Perrigo?
November 13, 2015 at 13:09 PM EST
Mylan’s (MYL) failed hostile takeout bid for rival generic drug maker Perrigo (PRGO) is hitting the two stocks in drastically different ways. Mylan, the supposed loser in this months-long fight, surged more than 13% to a recent $49 as investors rejoiced at the elimination of the dilution expected from Perrigo acquisition and the reversal of […]